CD8A and neoplasm: Some metabolites present in the tumor microenvironment, such as lysophosphatidic acid, can also disrupt IS formation by impairing F-actin accumulation in CD8+ T cells and altering microtubule dynamics, allowing tumor cells to evade death [102].